Shinichiroh Maekawa

Real‐world outcomes of pembrolizumab monotherapy in <scp>non‐small</scp> cell lung cancer in Japan: A post‐marketing surveillance

Nobuyuki Yamamoto, Tetsu Kamitani, Kingo Kanda et al. · Cancer Science · 2022 · 13 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

Masahiro Kimata, Asuka Watanabe, Yukiko Yanagida et al. · Infectious Diseases and Therapy · 2023 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +14

Real‐world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all‐case postmarketing surveillance in Japan

Naoya Yamazaki, Akiko Shimizu, Masahiko Ozaki et al. · The Journal of Dermatology · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan

Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata et al. · Infectious Diseases and Therapy · 2024 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

Ken Yoshikawa, Akira Tsuchiya, Tomoyuki Kido et al. · Advances in Therapy · 2020 · 10 citations · Full text

Medicine, Internal Medicine, Pharmacology +16